Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1007/s15010-020-01441-4

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Research output: Contribution to journal › Letter

Original language	English
Number of pages	2
Journal	Infection
Early online date	10 May 2020
DOIs	https://doi.org/10.1007/s15010-020-01441-4
Publication status	E-pub ahead of print - 10 May 2020

Cite this

Kow, C. S., & Hasan, S. S. (2020). Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. https://doi.org/10.1007/s15010-020-01441-4

@article{93763abad8bc4b13b7d697434c6cbcee,

title = "Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis",

keywords = "Glucocorticoid, immunoglobulin, COVID‑19",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = "5",

day = "10",

doi = "10.1007/s15010-020-01441-4",

language = "English",

journal = "Infection",

issn = "0300-8126",

publisher = "Urban und Vogel",

}

TY - JOUR

T1 - Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/5/10

Y1 - 2020/5/10

KW - Glucocorticoid

KW - immunoglobulin

KW - COVID‑19

UR - http://www.scopus.com/inward/record.url?scp=85084381774&partnerID=8YFLogxK

U2 - 10.1007/s15010-020-01441-4

DO - 10.1007/s15010-020-01441-4

M3 - Letter

JO - Infection

JF - Infection

SN - 0300-8126

ER -

Access to Document

10.1007/s15010-020-01441-4Licence: Unspecified

Link to publication in Scopus

Research Output

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Research output: Contribution to journal › Review article

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?

Research output: Contribution to journal › Review article

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Cite this

Access to Document

Related content

Research Output

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?